CXCL2 and neoplasm: Accordingly, we found that CXCL2+ CAFs may secrete complement C3 to interact with C1Q+ TAMs, mainly targeting the pro‐angiogenic gene VEGFA to maintain their M2‐like phenotype in chemoresistant tumours.